ArticleThe oncologist2021

Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer.

Santiago Cabezas-Camarero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.